FDA Medical Device Classifications

Updated November 16, 2024

Medical devices are integral to healthcare, ranging from simple tools like bandages to complex machines like pacemakers. The U.S. Food and Drug Administration (FDA) classifies these devices into three categories based on their risk level and intended use. This classification ensures that devices are safe and effective, guiding manufacturers in design, testing, and approval processes. Understanding the classification system is critical for medical device manufacturers, as it directly shapes regulatory requirements and market approval pathways.

Key Takeaways

• FDA classifies devices into Class I, II, or III based on risk.
• Class I (low risk) devices require general controls only.
• Class II (moderate risk) devices require special controls; most need 510(k).
• Class III (high risk) devices require Premarket Approval (PMA).
• Intended use and potential risks drive classification.
• Cybersecurity integration is critical for Class II and III device submissions.

Table of Contents

• Key Takeaways
• Overview of FDA Medical Device Classification System
• Class I Devices: Low Risk
• Class II Devices: Moderate Risk
• Class III Devices: High Risk
• Factors Influencing Classification
• Pathways to Market: 510(k), PMA, and De Novo
• Exemptions and Special Considerations
• Regulatory Considerations in Cybersecurity
• Medical Device Cybersecurity FAQs

Why this matters

The FDA's medical device classification system is the foundation of patient safety and device efficacy in the US market. Misunderstanding or misapplying these classifications causes costly delays, regulatory non-compliance, and market rejection. The stakes are especially high for Class II and Class III devices, which often include sophisticated software and connectivity that introduce cybersecurity vulnerabilities. The FDA's 'Cybersecurity in Medical Devices' Final Guidance, dated February 3, 2026, establishes that manufacturers must build security into design and development regardless of classification, proportional to risk. This guidance strengthens premarket submission expectations, requiring detailed cybersecurity documentation, threat modeling, and testing results. Adherence to relevant standards such as IEC 60601-1-10, ISO 14971, and AAMI TIR57 is necessary for demonstrating compliance. Together these standards and the FDA's guidance define what acceptable cybersecurity practice looks like, ensuring devices meet their intended clinical function and hold up against cyber threats.

Overview of FDA Medical Device Classification System

The FDA's classification system is defined under Title 21 of the Code of Federal Regulations (CFR). Devices are categorized into Class I, II, or III based on their risk to patients and users. The riskier a device is, the more stringent the regulatory controls. The system balances patient safety with the development and availability of innovative medical devices.

1. Class I Devices: Low Risk
2. Class II Devices: Moderate Risk
3. Class III Devices: High Risk

Class I Devices: Low Risk

Class I devices pose minimal risk to the user. Most Class I devices are subject to general controls, including basic regulatory requirements for all medical devices, such as proper labeling, adherence to good manufacturing practices (GMP), and device registration.

• Examples: Elastic bandages, tongue depressors, and manual stethoscopes.
• Regulatory Pathway: Most Class I devices do not require premarket notification (510(k)). However, a small subset may need to submit a 510(k) to demonstrate that the device is substantially equivalent to an existing legally marketed device.

Class I devices are the least regulated and comprise about 47% of all FDA-registered medical devices. Approximately 95% of these devices are exempt from the premarket notification process.

Class II Devices: Moderate Risk

Class II devices pose a moderate risk to the patient or user. These devices are subject to both general controls and special controls. Special controls can include specific labeling requirements, mandatory performance standards, and postmarket surveillance.

• Examples: Infusion pumps, powered wheelchairs, and surgical drapes.
• Regulatory Pathway: Most Class II devices require a 510(k) premarket notification. Through this process, manufacturers must demonstrate that their device is substantially equivalent to a legally marketed predicate device. The 510(k) pathway allows the FDA to confirm that new devices are as safe and effective as existing ones.

Special controls for Class II devices may include guidance documents, testing requirements, and specific design standards. These controls help manage the risks associated with device use and maintain consistency in safety and performance.

Class III Devices: High Risk

Class III devices are the highest risk category. They include devices that sustain or support life, are implanted, or present a high risk of illness or injury. Because of their critical nature, Class III devices face the most stringent regulatory controls.

• Examples: Implantable pacemakers, heart valves, and breast implants.
• Regulatory Pathway: Class III devices typically require a Pre-Market Approval (PMA), which involves a rigorous scientific review. Manufacturers must provide substantial evidence of safety and effectiveness through clinical trials and testing data.

The PMA process is resource-intensive, requiring detailed documentation, clinical study data, and proof that the device meets all applicable safety standards. Unlike the 510(k) pathway used for Class II devices, the PMA is a more thorough review, reflecting the higher stakes of Class III devices.

Factors Influencing Classification

See also: SPDF and IEC 62304 Mapping: FDA Cyber Guide, FDA Penetration Testing Requirements for Medical Devices, and Letter to File vs New 510(k) for Cybersecurity Changes.

The FDA considers several factors when classifying a medical device:

1. Intended Use: The primary function or purpose of the device is the primary driver. A surgical scalpel, for example, gets classified differently than a general-purpose blade used outside surgical procedures.
2. Level of Control Required: The need for special controls beyond general regulations determines whether a device falls into Class II or III.
3. Potential Risks: Devices that pose higher risks to patients, such as life-sustaining or life-supporting devices, are generally placed in Class III.

Pathways to Market: 510(k), PMA, and De Novo

The regulatory pathway for a device depends on its classification. The most common pathways include 510(k), PMA, and the De Novo classification process.

• 510(k) Pathway: This pathway is used primarily for Class II devices and involves demonstrating that a new device is "substantially equivalent" to an already legally marketed device. It is less demanding than the PMA, but manufacturers must provide detailed information about the device's design, function, and safety.
• PMA Pathway: Required for most Class III devices, the PMA process is a scientific review involving clinical trials and extensive testing data to prove that a device is safe and effective for its intended use.
• De Novo Classification: Manufacturers can pursue De Novo classification for new devices that do not have a predicate but are considered low to moderate risk. This process allows novel devices that don't fit existing classifications to be approved without meeting the more stringent requirements of a Class III PMA.

Exemptions and Special Considerations

While most devices follow these pathways, some exemptions apply:

• Exempt Class I Devices: Most Class I devices are exempt from premarket notification requirements due to their low risk.
• Exemptions for Some Class II Devices: The FDA has identified certain Class II devices that do not require a 510(k), often because the risk is well understood and manufacturing standards are well established.
• Humanitarian Device Exemption (HDE): This is a special pathway for Class III devices intended to benefit patients with rare conditions (affecting fewer than 8,000 individuals annually in the U.S.). HDE allows for a less rigorous approval process compared to a full PMA.

Regulatory Considerations in Cybersecurity

As devices become more complex and interconnected, cybersecurity is an increasingly important part of the submission package, especially for Class II and III devices that handle sensitive patient data or sit within critical healthcare infrastructure. Addressing cybersecurity from the design phase is required for FDA clearance. Secure software development and data protection are now integral to device submissions.

The FDA's guidance on premarket submissions requires risk management processes that include threat modeling and secure software development life cycle (SSDLC) practices. These requirements align with standards like IEC 62304, which governs software lifecycle processes for medical devices.

Conclusion: The Regulatory Landscape for Medical Devices

Understanding the FDA's classification system is essential for any manufacturer bringing a new device to market. Each class, whether low-risk Class I, moderate-risk Class II, or high-risk Class III, carries its own requirements and challenges. By understanding these distinctions and aligning product development with regulatory expectations, manufacturers can keep their path to market on track and deliver devices that are safe for patients and compliant with FDA requirements. With the FDA's increasing focus on cybersecurity, integrating security throughout the device lifecycle has become a core compliance requirement, especially for devices that connect to networks or process sensitive patient data.

Check out our premarket cybersecurity submission services.

How Blue Goat approaches this

Our approach to medical device cybersecurity aligns with FDA classifications, emphasizing compliance and security integration from the earliest design stages. For Class II and III devices, where regulatory scrutiny is highest, we provide in-depth premarket cybersecurity services, including threat modeling, risk assessments, and penetration testing. Our team, comprising experts with CISSP and OSCP certifications and ex-military red team experience, specializes in identifying and mitigating vulnerabilities specific to connected medical devices. We assist manufacturers in drafting the cybersecurity documentation required for 510(k) and PMA submissions, ensuring all necessary artifacts are present and rigorous. If the FDA raises cybersecurity deficiencies after our submission, we resolve them at no additional cost. We focus on practical, verifiable security measures that satisfy regulatory requirements and protect patients. Learn more about our services at https://www.bluegoatcyber.com/services/fda-premarket-cybersecurity-services.

FAQ

What are the three FDA medical device classifications?

The three FDA medical device classifications are Class I (low risk), Class II (moderate risk), and Class III (high risk). These classifications dictate the level of regulatory control required for each device.

What is a Class III medical device?

A Class III medical device is a high-risk device that sustains or supports life, is implanted, or presents a potential unreasonable risk of illness or injury. These devices undergo the most stringent regulatory review processes, typically requiring Premarket Approval (PMA).

Does the FDA require cybersecurity documentation for medical devices?

Yes, the FDA requires cybersecurity documentation for medical devices, particularly for "cyber devices." Manufacturers must provide evidence of a secure product development lifecycle, threat modeling, and plans for post-market vulnerability management in premarket submissions, per the February 3, 2026 final guidance.

What is the 510(k) pathway for FDA clearance?

The 510(k) pathway is a premarket submission to the FDA demonstrating that a device is substantially equivalent to a legally marketed predicate device. This pathway is primarily used for Class II medical devices and some Class I devices.

How does the FDA define 'intended use' for device classification?

The FDA defines 'intended use' as the general purpose of the device or its function, as described in its labeling. A device's intended use significantly influences its classification and the corresponding regulatory requirements.

About the author

Christian Espinosa, CISSP, Founder, Blue Goat Cyber. Christian leads a team focused exclusively on medical device cybersecurity for FDA premarket submissions and postmarket compliance. Read more about Christian.